東京科学大学 · 医学部

研究キーワードinflammatory bowel disease・ulcerative colitis・Crohn disease・tofacitinib・mucosal healing・intestinal imaging

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Matsuoka K, Yamazaki H, Nagahori M, Kobayashi T, Omori T, Mikami Y, Fujii T, Shinzaki S, Saruta M, Matsuura M, Yamamoto T, Motoya S, Hibi T, Watanabe M, Fernandez J, Fukuhara S, Hisamatsu T. Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study. Journal of gastroenterology. 2024.07; 59 (7): 644-646. ( PubMed , DOI )2024
• Shimizu H, Aonuma Y, Hibiya S, Kawamoto A, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Okamoto R. Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study. Intestinal research. 2024.07; ( PubMed , DOI )2024
• 長堀 正和. 【感染症を鑑別したあとは?非感染性腸炎を見極める!】代表的な非感染性腸炎の診療と紹介時の見極めかた 器質的異常に伴う大腸炎 憩室炎,虚血性腸炎ほか 診断と治療. 2024.03; 112 (3): 365-368. ( 医中誌 )2024
• Fujiwara S, Kawamoto A, Motobayashi M, Hibiya S, Takenaka K, Shimizu H, Saito E, Fujii T, Nagahori M, Kawata D, Umezawa N, Hosoya T, Yasuda S, Ohtsuka K, Okamoto R. Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab. DEN open. 2023.04; 3 (1): e196. ( PubMed , DOI )2023

• 公式プロフィール
• ORCID